A significant shift in Canadian drug policy has occurred, as the regulators announce the legalization of psilocybin hallucinogens for therapeutic treatment. Until now, these substances were severely restricted, but a growing body of evidence suggests they potentially offer benefits for emotional issues like depression. This development represents a